Zynex, Inc.
ZYXI
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device thaā¦ read more
Healthcare
Medical Distribution
21 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.29
Price+5.00%
$0.01
1Y
Price
Market Cap
$8.934m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-328.7%
EBITDA Margin-321.2%
Net Profit Margin-47.3%
Free Cash Flow MarginRevenue
$108.202m
-43.7%
1y CAGR-7.6%
3y CAGR-0.4%
5y CAGREarnings
-$73.958m
-2570.2%
1y CAGR-894.1%
3y CAGR-670.7%
5y CAGREPS
-$2.43
-2800.0%
1y CAGR-968.4%
3y CAGR-723.8%
5y CAGRBook Value
-$41.372m
$45.322m
Assets$86.694m
Liabilities$71.618m
DebtDebt to Assets
158.0%
-1.1x
Debt to EBITDAFree Cash Flow
-$20.997m
-272.9%
1y CAGR-91.8%
3y CAGR-41.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company